Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net sales	$ 1,735	$ 1,735	$ 5,305	$ 5,428
Cost of products sold	510	558	1,618	1,767
Gross profit	1,225	1,177	3,687	3,661
Operating expenses:
Selling, general and administrative expenses	658	589	1,950	1,895
Research and development expenses	217	220	644	648
Royalty expense	28	29	115	125
Amortization expense	101	99	305	294
Goodwill impairment charges	0	748	423	4,350
Intangible asset impairment charges	0	13	53	142
Contingent consideration (benefit) expense	23	(20)	(18)	(9)
Restructuring charges	19	54	55	93
Litigation-related charges	76	50	206	119
Gain on divestiture	0	(11)	(40)	(11)
Operating expenses	1,122	1,771	3,693	7,646
Operating income (loss)	103	(594)	(6)	(3,985)
Other income (expense):
Interest expense	(137)	(65)	(266)	(197)
Other, net	(6)	(4)	(10)	23
Income (loss) before income taxes	(40)	(663)	(282)	(4,159)
Income tax expense (benefit)	(35)	1	(53)	(30)
Net income (loss)	$ (5)	$ (664)	$ (229)	$ (4,129)
Net income (loss) per common share — basic	$ 0.00	$ (0.48)	$ (0.17)	$ (2.91)
Net income (loss) per common share — assuming dilution	$ 0.00	$ (0.48)	$ (0.17)	$ (2.91)
Weighted-average shares outstanding
Basic	1,340.3	1,392.5	1,345.2	1,420.3
Assuming dilution	1,340.3	1,392.5	1,345.2	1,420.3